Filed: 2/13/2024ACC: 0001214659-24-002438
📋 What this filing means
SIO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 43 equity positions with a total reported market value of $439.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
43
Positions
$439.20M
Total AUM (reported)
22.88M
Total Shares
Allocation by class
COM$245.09M55.8%
SPONSORED ADS$52.42M11.9%
COM NEW$48.38M11.0%
CL A$28.36M6.5%
COM PAR $.01$26.70M6.1%
SPONSORED ADR$21.18M4.8%
COMMON STOCK$13.93M3.2%
Portfolio Concentration
Top 3$173.05M39.4%
4–10$161.78M36.8%
11–25$91.67M20.9%
Rest$12.71M2.9%
Top 3 weight
39.4%
Top 10 weight
76.2%
Voting Authority Distribution
Total shares with voting rights: 22.88M
Sole
Full voting authority
22.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole43
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings43
Rows:
MIRATI THERAPEUTICS INC
SOLEShares1.45M
TypeSH
Market value$85.30M
19.42%
Sole
1.45M
Shared
0.00
None
0.00
GRACELL BIOTECHNOLOGIES INC
SOLEShares5M
TypeSH
Market value$50.22M
11.43%
Sole
5M
Shared
0.00
None
0.00
LABORATORY CORP AMER HLDGS
SOLEShares165.12K
TypeSH
Market value$37.53M
8.55%
Sole
165.12K
Shared
0.00
None
0.00
THE CIGNA GROUP
SOLEShares116.55K
TypeSH
Market value$34.90M
7.95%
Sole
116.55K
Shared
0.00
None
0.00
GLOBUS MED INC
SOLEShares532.09K
TypeSH
Market value$28.36M
6.46%
Sole
532.09K
Shared
0.00
None
0.00
INSMED INC
SOLEShares861.70K
TypeSH
Market value$26.70M
6.08%
Sole
861.70K
Shared
0.00
None
0.00
GSK PLC
SOLEShares571.39K
TypeSH
Market value$21.18M
4.82%
Sole
571.39K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares644.37K
TypeSH
Market value$19.11M
4.35%
Sole
644.37K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares80.05K
TypeSH
Market value$17.60M
4.01%
Sole
80.05K
Shared
0.00
None
0.00
EMBECTA CORP
SOLEShares736.01K
TypeSH
Market value$13.93M
3.17%
Sole
736.01K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares141.30K
TypeSH
Market value$13.63M
3.10%
Sole
141.30K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares460.04K
TypeSH
Market value$10.55M
2.40%
Sole
460.04K
Shared
0.00
None
0.00
TELEFLEX INCORPORATED
SOLEShares36.53K
TypeSH
Market value$9.11M
2.07%
Sole
36.53K
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares72.30K
TypeSH
Market value$8.80M
2.00%
Sole
72.30K
Shared
0.00
None
0.00
NEOGEN CORP
SOLEShares427K
TypeSH
Market value$8.59M
1.96%
Sole
427K
Shared
0.00
None
0.00
HEALTHCARE SVCS GROUP INC
SOLEShares810.31K
TypeSH
Market value$8.40M
1.91%
Sole
810.31K
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$6.06M
1.38%
Sole
1.11M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares131.75K
TypeSH
Market value$5.32M
1.21%
Sole
131.75K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares971.45K
TypeSH
Market value$4.33M
0.99%
Sole
971.45K
Shared
0.00
None
0.00
MERRIMACK PHARMACEUTICALS IN
SOLEShares288.47K
TypeSH
Market value$3.87M
0.88%
Sole
288.47K
Shared
0.00
None
0.00
HARPOON THERAPEUTICS INC
SOLEShares297.94K
TypeSH
Market value$3.39M
0.77%
Sole
297.94K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares3.59M
TypeSH
Market value$3.01M
0.69%
Sole
3.59M
Shared
0.00
None
0.00
FUSION PHARMACEUTICALS INC
SOLEShares246.04K
TypeSH
Market value$2.36M
0.54%
Sole
246.04K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares251.53K
TypeSH
Market value$2.20M
0.50%
Sole
251.53K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares635.97K
TypeSH
Market value$2.05M
0.47%
Sole
635.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MIRATI THERAPEUTICS INCSOLE | COM | 1.45M | SH | $85.30M 19.42% | 1.45M | 0.00 | 0.00 |
GRACELL BIOTECHNOLOGIES INCSOLE | SPONSORED ADS | 5M | SH | $50.22M 11.43% | 5M | 0.00 | 0.00 |
LABORATORY CORP AMER HLDGSSOLE | COM NEW | 165.12K | SH | $37.53M 8.55% | 165.12K | 0.00 | 0.00 |
THE CIGNA GROUPSOLE | COM | 116.55K | SH | $34.90M 7.95% | 116.55K | 0.00 | 0.00 |
GLOBUS MED INCSOLE | CL A | 532.09K | SH | $28.36M 6.46% | 532.09K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 861.70K | SH | $26.70M 6.08% | 861.70K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 571.39K | SH | $21.18M 4.82% | 571.39K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 644.37K | SH | $19.11M 4.35% | 644.37K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 80.05K | SH | $17.60M 4.01% | 80.05K | 0.00 | 0.00 |
EMBECTA CORPSOLE | COMMON STOCK | 736.01K | SH | $13.93M 3.17% | 736.01K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 141.30K | SH | $13.63M 3.10% | 141.30K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 460.04K | SH | $10.55M 2.40% | 460.04K | 0.00 | 0.00 |
TELEFLEX INCORPORATEDSOLE | COM | 36.53K | SH | $9.11M 2.07% | 36.53K | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 72.30K | SH | $8.80M 2.00% | 72.30K | 0.00 | 0.00 |
NEOGEN CORPSOLE | COM | 427K | SH | $8.59M 1.96% | 427K | 0.00 | 0.00 |
HEALTHCARE SVCS GROUP INCSOLE | COM | 810.31K | SH | $8.40M 1.91% | 810.31K | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 1.11M | SH | $6.06M 1.38% | 1.11M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 131.75K | SH | $5.32M 1.21% | 131.75K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 971.45K | SH | $4.33M 0.99% | 971.45K | 0.00 | 0.00 |
MERRIMACK PHARMACEUTICALS INSOLE | COM NEW | 288.47K | SH | $3.87M 0.88% | 288.47K | 0.00 | 0.00 |
HARPOON THERAPEUTICS INCSOLE | COM NEW | 297.94K | SH | $3.39M 0.77% | 297.94K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 3.59M | SH | $3.01M 0.69% | 3.59M | 0.00 | 0.00 |
FUSION PHARMACEUTICALS INCSOLE | COM | 246.04K | SH | $2.36M 0.54% | 246.04K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 251.53K | SH | $2.20M 0.50% | 251.53K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 635.97K | SH | $2.05M 0.47% | 635.97K | 0.00 | 0.00 |
Page 1 of 2